• Explore /
  • Poster
  • / A phase I/pilot study of CPX-351 for children, adolescents and young adults with recurrent or refractory hematologic malignancies.

A phase I/pilot study of CPX-351 for children, adolescents and young adults with recurrent or refractory hematologic malignancies.

Abstract Poster

Authors

Michael Absalon

Michael Absalon

Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Michael Absalon , Maureen Megan O'Brien , Christine L. Phillips , Karen Cristly Burns , Jennifer Mangino , Benjamin Mizukawa , Erin Haag Breese , Rachana Shah , John Peter Perentesis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Leukemia/Lymphoma

Citation

J Clin Oncol 34, 2016 (suppl; abstr 10541)

DOI

10.1200/JCO.2016.34.15_suppl.10541

Abstract #

10541

Poster Bd #

232

Abstract Disclosures

Similar Posters

First Author: Todd Michael Cooper

First Author: Amy Yuan Wang

First Author: Byung-Kiu Park

First Author: Jessica Hochberg